Hogan Lovells 2024 Election Impact and Congressional Outlook Report
As a part of the Food and Drug Administration’s (FDA’s) initiative to modernize and reform dietary supplement oversight, FDA announced it will hold a public meeting on responsible innovation in dietary supplement manufacturing on May 16, 2019.
FDA also recently unveiled a new Dietary Supplement Ingredient Advisory List, a rapid-response tool intended to quickly alert the public when FDA identifies ingredients that do not appear to be lawfully marketed dietary supplements. FDA has listed four ingredients on the list so far: andarine, higenamine, hordenine, and 1,4-DMAA. This memorandum summarizes these developments.
Authored by Martin Hahn and Samantha Dietle